Exploring the mechanisms behind the effects of chronic bovine colostrum supplementation on risk of upper respiratory tract infection

Arwel Wyn Jones, Simon John Cameron, Rhys Thatcher, Marikka Shannon Beecroft, Luis Mur, Glen Davison

Research output: Contribution to conferenceAbstract


Chronic bovine colostrum (COL) supplementation has been shown to reduce the incidence of upper respiratory tract infection (URTI) but the underlying mechanism remains unclear. Fifty seven highly active males (aged 18-62) were randomised to daily supplementation of 20g of COL (N = 28) or an isoenergetic/isomacronutrient placebo (PLA) (N = 29) for 12 weeks under double-blind procedures. Daily illness and weekly activity logs were completed. Resting blood samples collected at baseline and at 12 weeks were analysed for total/differential leukocyte counts and in-vitro stimulated neutrophil oxidative burst. Metabolomic profiling of serum samples at these timepoints was performed using fourier transform infrared spectroscopy and direct-infusion – electrospray-ionisation – mass spectroscopy. Secretory IgA and bacterial load were measured within saliva samples obtained at baseline, 4, 8 and 12 weeks using enzyme-linked immunosorbent assay and real-time, quantitative PCR methods respectively. The mean number of URTI episodes was significantly higher (P < 0.05) in the PLA group (0.8 ± 0.7) than in COL group (0.5 ± 0.7). There were a significantly greater proportion of days with URTI symptoms in the PLA group (P < 0.001) compared to COL group. No statistical differences were found between leukocyte counts, neutrophil oxidative burst or salivary IgA across time or between groups (P > 0.05). However, Discriminant Function Analyses (DFA) of outputs received from the metabolomic profiling showed a significant difference between COL and PLA at 12 weeks (P < 0.05). Interrogation of the loading vectors in the DFA models indicated 10 metabolites which contributed most to the difference between COL and PLA which included, but were not limited to, decreased noradrenaline, uric acid, and dehydroascorbic acid with COL (P<0.05). There was a general increase in bacterial load within groups, over the 12 week period, but this increase was significantly lower (P < 0.05) with COL. These findings support previously reported evidence regarding the effects of COL on URTI incidence. Although the lack of effect on immune measures does not support some of the previously suggested mechanisms (e.g. improved resting salivary IgA concentration) some further sample analysis is currently outstanding. Also, the effects on the responses to exercise (which were not assessed in this study) may explain the lower URTI incidence and bacterial load with COL in these athletes. The differences observed in metabolomics profiling highlights novel potential mechanisms behind the effect of COL on infection risk, but outstanding analyses mentioned above and further study is required to verify this.
Original languageEnglish
Publication statusPublished - 2013
Event11th International Society of Exercise and Immunology symposium - Newcastle, Australia
Duration: 09 Sept 201312 Sept 2013


Conference11th International Society of Exercise and Immunology symposium
Abbreviated title11th ISEI symposium
Period09 Sept 201312 Sept 2013
OtherThe 2013 symposium theme was “Exercise Immunology: Prescriptions for Health” and featured several exciting scientific sessions that highlighted the importance of regular physical activity to maintain health across the lifespan. This year we extended our discussions beyond the direct modulatory effects of exercise on the immune system, to include exercise and regular physical activity effects on the mind/brain, gut and respiratory systems and muscle.


Dive into the research topics of 'Exploring the mechanisms behind the effects of chronic bovine colostrum supplementation on risk of upper respiratory tract infection'. Together they form a unique fingerprint.

Cite this